Status:
COMPLETED
18F-DOPA-PET in Non-tumoral and Tumoral Brain Lesions
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Brain Tumor
Eligibility:
All Genders
18+ years
Brief Summary
Background: 3,4-dihydroxy-6-\[18F\]-fluoro-L-phenylalanine (FDOPA) positron emission tomography (PET) can identify well low and high grade brain tumors. However, increased FDOPA uptake has been report...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- presence of defined tumor (histology was required) or non-tumor (diagnosed by histological or other analyses) diagnosis,
- clinical and MRI follow-up of \>24 months,
- FDOPA-PET scan \<2 months before surgery or stereotactic biopsy (when performed)
Exclusion
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04306484
Start Date
January 1 2020
End Date
December 31 2020
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes
Nîmes, France, 30029